Participation in the TechShare kick off meeting organized by Euronext
The ENYO team was present at the TechShare kick off meeting on Friday, September 21th, 2018. TechShare is a unique pan-European programme organized by Euronext to boost the funding of innovative companies by financial markets. On this occasion, Euronext has welcomed the 135 non listed most promising European start-ups in order to develop the minimum skills to be listed on stock market. This programme, organized for the 4th consecutive year, has allowed ENYO Pharma to understand the benefits and disadvantages to choose this type of financing to support the company’s growth.
Read next in 'Latest news'
- Orphan Drug Designation (ODD) granted to Vonafexor for Alport syndrome by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA)
- New publication: Hepatic and renal improvements with FXR agonist Vonafexor in individuals with suspected fibrotic NASH
- New publication : An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters
- Swiss NASH Foundation sponsorship
- ENYO Pharma in the Top 50 of the EIC ScalingUp List